Alexis Zambrano

Cardiology Resident @cardiologia_mx | Internal Medicine Specialist @cmn20noviembre 🫀

[Alexis Zambrano @AlexisZmbrano]

A great experience presenting our research at #ESCCongress in Munich. 🌍

We shared our work on late-presenting #STEMI, exploring the association between clinical indication and angiographic success after #PCI. @escardio 🫀

[NEJM @NEJM]

Presented at #ESCCongress:

Among patients with ST-segment elevation myocardial infarction and multivessel disease, physiology-guided angiography led to a lower risk of major cardiovascular events than conventional angiography-guided treatment. Full AIR-STEMI trial results: https://t.co/NcPWnhsoak

@escardio

[Alfonso Jurado-Román @JuradoRomanAl]

Happy to participate in the first volume of @EuroInterventio Case Reports. “Bailout #ELCA for guide wire entrapment”
Great job @MattiaBasile97 as always 👏🏾👏🏾 @shci_sec @PCRonline @Hemodin_LaPaz @CardioHULP

[Salvatore Brugaletta @sbrugaletta]

slow flow and no reflow are the final result of a microvascular obstruction during PCI. In this state-of-the-art review we tried to provide a comprehensive overview of the pathophysiological mechanisms underlying this phenomenon, as well as invasive and non-invasive diagnostic tools, and finally, pharmacological and interventional treatments, highlighting the clinical gaps in the field. there is not much in this field but it may be a topic of the future for PCI. thanks @DFCapodanno for inviting us. it was a great team work @Ortega_Paz @LaudaniClaudio Manel Sabate and our coming fellow at @hospitalclinic Michele Strosio @PCRonline @EuroInterventio @secardiologia @shci_sec @hbellvitge @TCTMD @ACCinTouch https://t.co/oWHi1uCZ6S

[Almudena Castro Conde @almucastro01]

Muy contenta con los resultados del ÓRBITA-CTO

Un estudio exquisito metodológicamente con resultados a favor de PCI en oclusiones crónicas de los pacientes con angina.

Porque la calidad de vida es un endpoint duro y tenemos que empezar a cambiar el chip.
#LaSECteLleva #ACC26

[Alfonso Jurado-Román @JuradoRomanAl]

Happy to share the publication of the #RollerCoastrTrial ROtational atherectomy, Lithotripsy or LasER for Calcified cOronAry STEnosis: Randomized evidence to support our decisions when choosing plaque modification techniques @JACCJournals @shci_sec

https://t.co/VAoCwevqFZ

[Alfonso Jurado-Román @JuradoRomanAl]

Excimer Laser coronary Atherectomy in contemporary PCI: from the classic 5Ss to the new 3 Ss. Thx to @MattiaBasile97 and my friends who also collaborated with us in this idea; the authors of the original “5Ss” @MohanedEgred @esbrilakis 🙏 @EuroInterventio
https://t.co/patyL6h6wz

[Alexis Zambrano @AlexisZmbrano]

Honored to meet @Bweber04 during #ESCCongress2025, after my presentation on autoimmune and cardiovascular disease, a true leader in cardio-rheumatology. @escardio

[Alexis Zambrano @AlexisZmbrano]

🆕 Report of interesting case

https://t.co/CUsOwPR9wJ

[Alexis Zambrano @AlexisZmbrano]

@Jessica1222_ Thank you so much for reviewing the article! I completely agree. Glad you found it useful 🙏🏼

[Alexis Zambrano @AlexisZmbrano]

Review: Heart Failure in Rheumatoid Arthritis.

Underdiagnosed‼️
The role of inflammation is key, and its control reduces onset and progression. 🔑

Current Heart Failure Reports
https://t.co/kGVFGgwGPF

[NEJM @NEJM]

Presented at #ACC24:

Hospitalized patients with acute myocardial infarction & preserved EF were assigned to receive open-label long-term beta-blocker therapy or not. Beta-blockers did not lead to a lower risk of death or MI. Full REDUCE-AMI trial results: https://t.co/z1NNeAK9Mm

[JACC Journals @JACCJournals]

New leading edge commentary now in #JACCHF by Drs. @lamcardio and @pmyhre on #ARNI implementation across the spectrum of #heartfailure.

Excellent primer on ARNI efficacy in chronic and subacute #HFrEF and #HFpEF, stage B+D HF. https://t.co/GNtcAE4MIn

[Alexis Zambrano @AlexisZmbrano]

Congreso Mexicano de Cardiología
- Abordaje de cardiomiopatía 🇲🇽

[nature @Nature]

This week in Nature: Mexican genomics – biobanks offer genetic insights into the diverse population of Mexico. Browse the full issue here: https://t.co/ECfydSnxtq

[Alexis Zambrano @AlexisZmbrano]

@EduardoAg94 Doblemente felicidades amigo! 👏🏼

[European Society of Cardiology Journals @ESC_Journals]

#RenalFunction and #decongestion with acetazolamide in Acute decompensated #HeartFailure: the ADVOR trial 👉

https://t.co/iwwJihDnEq

#ESCCongress #EHJ @ehj_ed @rladeiraslopes

[Alfonso Valle @ValleAlfonso]

⚠️Management of CV disease in patients with type 2 diabetes 👉2023 @escardio Guidelines

👉 To reduce CV risk independent of glucose control: GLP1+iSGLT2

📥 https://t.co/SFTeTCXM7q #ESCcongress @riesgo_SEC

[European Society of Cardiology Journals @ESC_Journals]

New-onset atrial fibrillation prediction: the HARMS2-AF risk score https://t.co/UZSYqCSRbz

@escardio #EHJ #ESCYoung @ehj_ed @rladeiraslopes

[Emanuele Monda @MondaEmanuele]

Left Atrial Strain for Assessment of Left Ventricular Diastolic Function Focus on Populations With Normal LVEF

@JACCJournals

https://t.co/sJEf5wKSHh